• br Introduction Epidermal growth factor

  2019-07-02

  

  Introduction Epidermal growth factor receptor (EGFR)-activating-mutant non-small cell lung cancer (NSCLC) often initially responds well to EGFR tyrosine kinase inhibitors (TKIs) (Haber et al., 2011); however, the disease almost always recurs about 10–13 months of therapy. Analysis of clinical spe

• Acidic substituents showed moderate biochemical activity but

  2019-07-02

  

  Acidic substituents () showed moderate biochemical activity, but these compounds showed reduced cellular potency. Additional compounds bearing a carboxylic Nilotinib were also prepared and tested (data not shown). All of acidic compounds showed low cellular potency regardless of their biochemical a

• br Acknowledgements These studies were supported by a resear

  2019-07-02

  

  Acknowledgements These studies were supported by a research grant from the NIH (R01 AR065594) to C. Putterman. Introduction Macrophages integrate and adapt to their locally encountered cytokine and chemokine milieu. In tumors characterized by an unresolving inflammation, the tumor cell-killin

• Among prostaglandins PG PGD remained the

  2019-07-02

  

  Among prostaglandins (PG), PGD2 remained the most elusive species for a long time and was initially regarded as having negligible biological activity [1]. In 1974 its inhibitory effect on platelet aggregation was discovered by Smith et al. [2] and Mills & McFarlain [3], and both pressor and depresso

• In summary A is a

  2019-07-02

  

  In summary, A-216546 is a potent, orally available endothelin receptor antagonist with a high selectivity for the endothelin ETA receptor. The potency and bioavailability of A-216546 suggest that it will have important utility for preclinical evaluation of the pathophysiology of the endothelin syste

• br STAR Methods br Acknowledgments We thank members of

  2019-07-02

  

  STAR★Methods Acknowledgments We thank members of R.L. lab and F. Schweisguth for critical reading of the manuscript. We are also grateful to F. Janody, M. Miura, C. Bökel, H.D. Ryoo, G. Jiménez, the Bloomington Drosophila Stock Center, the Drosophila Genetic Resource Center, the Vienna Drosoph

• For the current studies we used the selective Epac

  2019-07-02

  

  For the current studies, we used the selective Epac agonist 8CPT-AM to directly activate the proteins. We chose this pharmacological approach since it allows a direct activation of Epacs rather than using receptor agonists such as PGE2 which could introduce confounding variables. One potential conce

• In summary synthetic routes with moderate to high yields hav

  2019-07-01

  

  In summary, synthetic routes with moderate to high yields have been developed to produce difluoro-dioxolo-benzoimidazol-benzamides including reference standards and , and -desmethylated precursors and , and carbon-11-labeled difluoro-dioxolo-benzoimidazol-benzamides target tracers [C] and [C]. The r

• br We recently reported associations

  2019-07-01

  

  We recently reported associations between maternal age at childbirth and outcomes in the offspring, using data from five birth cohorts (COHORTS collaboration) in low-income and middle-income countries (LMICs), in . Young maternal age ( Antimicrobial resistance is recognised as a serious global he

• We did a qualitative analysis to estimate the potential

  2019-07-01

  

  We did a qualitative analysis to estimate the potential risk of Zika What\'s New introduction into the country. We used the circlize statistical package for R software to visualise incoming traffic (logarithm of relative passenger volume) to Pakistani airports from countries characterised as Zika-v

• br Discussion The site of the successful ablation

  2019-07-01

  

  Discussion The site of the successful ablation was the earliest site where a TSP was recorded during tachycardia. The TSP preceded each His bundle deflection by 15ms during tachycardia, but was inverted during atrial pacing. Moreover, the TSP–His deflection interval remained unchanged at differen

• br Role of ICD treatment In

  2019-07-01

  

  Role of ICD treatment In patients with VT associated with various structural NMS-873 diseases, ICD therapy is recommended even if the target VT is successfully ablated and no VT is inducible after catheter ablation [29]. This is because, in such patients, the same VT and/or new VT recurs during

• Biological mechanisms have also been associated with poor ca

  2019-07-01

  

  Biological mechanisms have also been associated with poor cardiovascular outcomes in ICD patients with depression, such as alteration of cardiac autonomic tone, activation of the sympathetic nervous system, enhanced activity of the hypothalamic-pituitary-adrenal axis, and elevated inflammatory and p

• In our study we observed that MT produced a improvement

  2019-07-01

  

  In our study we observed that MT produced a 50% improvement in the % area of tissues covered over that of H&E. It is possible that its three-in-one (trichrome) combination of dyes may be responsible for the large % area covered and high intensity measurement. This is in line with the report of Stree

• Implementation of contemporary treatment protocols incorpora

  2019-07-01

  

  Implementation of contemporary treatment protocols, incorporating adjuvant chemotherapy, have resulted in an improvement in the prognosis of patients diagnosed with osteosarcoma over the past decades. The overall 5-year survival rate has improved from less than 20% in the 1960s to approximately 60%

15067 records 942/1005 page Previous Next First page 上5页 941942943944945 下5页 Last page